Ablynx Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Innate Pharma.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |
Founding Date | Founding Date 2008 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 15815% increase | Employees 181 |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 148.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) €2.8m (FY, 2025) |
Net income | Net income ($17.4m) (FY, 2025) | Net income (€49.2m) (FY, 2025) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 3 (Q2, 2019) |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 4 (FY, 2016) | Pre-Clinical Phase Products 7 (Q2, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 132.4m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company